Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke | Zendy

Stefan Greisenegger | Zendy; Helen Segal | Zendy; A I Burgess | Zendy; Debbie L. Poole | Zendy; Ziyah Mehta | Zendy; Peter M. Rothwell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke

Author(s) -

Stefan Greisenegger,

Helen Segal,

A I Burgess,

Debbie L. Poole,

Ziyah Mehta,

Peter M. Rothwell

Publication year - 2015

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.011021

Subject(s) - medicine , copeptin , hazard ratio , cardiology , stroke (engine) , myocardial infarction , proportional hazards model , confidence interval , population , vascular disease , mechanical engineering , environmental health , engineering , vasopressin

Copeptin, the c-terminal portion of provasopressin, is a useful prognostic marker in patients after myocardial infarction and heart failure. More recently, high levels of copeptin have also been associated with worse functional outcome and increased mortality within the first year after ischemic stroke and transient ischemic attack (TIA). However, to date, there are no published data on whether copeptin predicts long-term risk of vascular events after TIA and stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research